Replies to post #710783 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

First, you do know the importance of peer-reviewed papers. Do you read Dr.Liau's papers? Why can't you have respect for the JAMA paper?

Second, did you read carefully what I posted? I was talking about industry-scale manufacturing systems. Not some experimental systems the paper is about.

[biosectinvestor]

The reason it is irrelevant is that is is not part of any major trial that will have a drug
With similar results available any time soon. And the other issue is that the space for DC’s is far, far faster than CAR—T where there are numerous competitors in a small area who are highly competitive and yet companies have been able to get bought for substantial sums despite not having the ability to manufacture their products at scale.

Trying to manufacture anxiety based on papers is really not all that compelling and honestly, even if real would say nothing much competitively. Technologies can be licensed and improved including competitive ones with Flaskworks as we have seen recently for NWBO and DCVaccine technology. This company or its inheritor will be far ahead of any competitors and will be attractive to most to potential strike a deal.